Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/D000077546
http://purl.bioontology.org/ontology/MESH/D000077546
|
|---|---|
| Preferred Name | Roscovitine |
| Definitions |
A purine derivative and competitive inhibitor of CYCLIN-DEPENDENT KINASES that has therapeutic potential as an antineoplastic and antiviral agent.
|
| Synonyms |
CYC202
2-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine
(2R)-2-((6-Benzylamino-9-(propan-2-yl)-9H-purin-2-yl)amino)butan-1-ol
Seliciclib
R roscovitine
R-roscovitine
CYC-202
CYC 202
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A purine derivative and competitive inhibitor of CYCLIN-DEPENDENT KINASES that has therapeutic potential as an antineoplastic and antiviral agent. |
|---|---|
| altLabel |
CYC202
2-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine
(2R)-2-((6-Benzylamino-9-(propan-2-yl)-9H-purin-2-yl)amino)butan-1-ol
Seliciclib
R roscovitine
R-roscovitine
CYC-202
CYC 202
See more
See less
|
| prefLabel | Roscovitine
|
| Machine permutation | 2019; ROSCOVITINE was indexed under PURINES 1997-2018
|
| HN | 2019 (1997)
|
| type | |
| isa | |
| PA |
D000998
D047428
D000970
|
| tui |
T109
T121
|
| TERMUI |
T652557
T652556
T578650
T578651
T000940131
T000940132
T000940130
T578652
See more
See less
|
| TH |
NLM (1997)
NLM (2004)
NLM (2005)
FDA SRS (2017)
INN (19XX)
NLM (2017)
See more
See less
|
| MMR | 20190101
|
| notation | D000077546
|
| Semantic type UMLS property | |
| Inverse of AQ |
See more
See less
|
| DX | 20190101
|
| cui |
C1609861
C4759697
C1610414
C0536217
C1436187
|
| DC | 1
|
| MN | D03.633.100.759.776
|
| LT | TRD
|
| AQL | AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
| Inverse of RB |
0ES1C2KQ94
0
|
| MDA | 20180207
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |